PASELLO, GIULIA

PASELLO, GIULIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 145 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts) 2021 Dal Maso, A.Ferro, A.Pretelli, G.Frega, S.Menis, J.Pasello, G.Guarneri, V.Conte, P. F.Bonanno, L. + JOURNAL OF THORACIC ONCOLOGY - -
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 2020 Dal Maso, A.Ferro, A.Lorenzi, M.Scattolin, D.Frega, S.Bonanno, L.Indraccolo, S.Calabrese, F.Guarneri, V.Conte, P. F.Pasello, G. + ANNALS OF ONCOLOGY - -
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 2021 Lorenzi, M.Dal Maso, A.Ferro, A.Scattolin, D.Indraccolo, S.Frega, S.Menis, J.Bonanno, L.Guarneri, V.Conte, P. F.Pasello, G. + JOURNAL OF THORACIC ONCOLOGY - -
166P: Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series 2016 Pasello, GFREGA, STEFANOIndraccolo, SFASSAN, MATTEOBonanno, LCONTE, PIERFRANCOCALABRESE, FIORELLA + JOURNAL OF THORACIC ONCOLOGY - -
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 2019 Evangelista L.Cuppari L.Menis J.Bonanno L.Frega S.Pasello G. + NUCLEAR MEDICINE COMMUNICATIONS - -
28P Different genetic profiling in lung adenocarcinoma of smokers with and without chronic obstructive pulmonary disease (COPD): An exploratory analysis by next generation sequencing (NGS) 2016 Bonanno, L.SCHIAVON, MARCOLUNARDI, FRANCESCAPASELLO, GIULIACONTE, PIERFRANCOREA, FEDERICOINDRACCOLO, STEFANOCALABRESE, FIORELLA + JOURNAL OF THORACIC ONCOLOGY - -
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 2021 Bonanno, L.Dal Maso, A.Zulato, E.Fassan, M.Pasello, G.Guarneri, V.Calabrese, F.Rea, F.Indraccolo, S.Conte, P. F. + JOURNAL OF THORACIC ONCOLOGY - -
77P Glycolytic marker monocarboxylate transporter 4 (MCT4) and outcome to bevacizumab (bev): An exploratory analysis in advanced non-small cell lung cancer (A-NSCLC) 2016 Bonanno, LCALABRESE, FIORELLAPasello, GConte, P. F + JOURNAL OF THORACIC ONCOLOGY - -
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry 2022 Giulia Pasello + JOURNAL OF THORACIC ONCOLOGY - -
A multi-center, real-life experience on liquid biopsy practice for EGFR testing in non-small cell lung cancer (NSCLC) patients 2020 Pasello G.Nardo G.Scquizzato E.Miorin M.Giovanis P.Corvaja C.Indraccolo S. + DIAGNOSTICS - -
A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report. 2010 Pasello GBonanno LREA, FEDERICO + JOURNAL OF THORACIC DISEASE - -
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 2022 Pasello, Giulia + FUTURE ONCOLOGY - -
A triple rare E709K and L833V/H835L EGFR mutation responsive to an irreversible pan-HER inhibitor: A case report of lung adenocarcinoma treated with afatinib 2016 FREGA, STEFANOCONTE, PIERFRANCOFASSAN, MATTEOPOLO, VALENTINAPASELLO, GIULIA JOURNAL OF THORACIC ONCOLOGY - -
Additional Value of PET and CT Image-Based Features in the Detection of Occult Lymph Node Metastases in Lung Cancer: A Systematic Review of the Literature 2023 Marturano, FrancescaBettinelli, AndreaPasello, GiuliaEvangelista, Laura + DIAGNOSTICS - -
An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma 2013 Pasello G. + CANCER TREATMENT REVIEWS - -
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) 2020 Pasello G.Chella A.Grilli G.Mandruzzato M.Grossi F.Ardizzoni A. + THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - -
Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature 2016 Russo, IrenePasello, GiuliaALAIBAC, MAURO SALVATORE ALESSANDRO + EXPERIMENTAL AND THERAPEUTIC MEDICINE - -
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 2018 FABBRI COLABICH, ALESSANDRAFranceschini, DavidePasello, GiuliaSchiavon, MarcoDei Tos, Angelo PaoloRea, FedericoCalabrese, Fiorella + CANCER TREATMENT REVIEWS - -
Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma. 2013 MARULLI, GIUSEPPEPERISSINOTTO, EGLEPasello GREA, FEDERICO + EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY - -
Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel) 2019 Dal Maso, A.Piccin, L.Pasello, G.Guarneri, V.Conte, P. F.Bonanno, L. + ANNALS OF ONCOLOGY - -